Patents-Review.com
🔗 Permalink
Assignee profile:

CRITITECH, INC.

City:

Lawrence, Kansas

Country:

United States

Published Applications:

35

Last publication date:

2024-08-01

Patent Grants:

33

Last grant date:

2025-06-17

Top Inventors for applications by CRITITECH, INC.

These are the the leading inventors for applications assigned to CRITITECH, INC.:

Recent patent applications by CRITITECH, INC.

CRITITECH, INC. based in Lawrence, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-08-01 ✅ Patent 12,329,858 granted on 2025-06-17
US20240252441A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

 #2 | 2023-11-23 ✅ Patent 12,128,131 granted on 2024-10-29
US20230372234A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

 #3 | 2023-08-24 ✅ Patent 11,918,691 granted on 2024-03-05
US20230263731A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

 #4 | 2023-06-08 ✅ Patent 12,390,459 granted on 2025-08-19
US20230172927A1
Human necessities

METHODS FOR SOLID TUMOR TREATMENT

 #5 | 2023-05-11 ✅ Patent 11,738,014 granted on 2023-08-29
US20230142591A1
Human necessities

Niraparib particles and uses thereof

 #6 | 2023-05-11 ✅ Patent 11,738,029 granted on 2023-08-29
US20230142186A1
Human necessities

Rucaparib particles and uses thereof

 #7 | 2023-04-13 ✅ Patent 11,737,972 granted on 2023-08-29
US20230111288A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

 #8 | 2022-11-24 ✅ Patent 12,029,818 granted on 2024-07-09
US20220370355A1
Human necessities

Lapatinib particles and uses thereof

 #9 | 2022-02-17 ✅ Patent 11,583,499 granted on 2023-02-21
US20220047513A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

 #10 | 2021-08-26 ✅ Patent 11,523,983 granted on 2022-12-13
US20210259959A1
Human necessities

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

 #11 | 2021-01-07 ✅ Patent 10,993,927 granted on 2021-05-04
US20210000786A1
Human necessities

Taxane particles and their use

 #12 | 2020-08-20 ✅ Patent 11,058,639 granted on 2021-07-13
US20200261367A1
Human necessities

Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer

 #13 | 2020-08-06 ✅ Patent 11,104,663 granted on 2021-08-31
US20200247780A1
Chemistry; metallurgy

Ciprofloxacin polymorph and its use

 #14 | 2020-08-06 ✅ Patent 11,931,368 granted on 2024-03-19
US20200246355A1
Human necessities

Glucocorticoid “nintedanib” particles and their use

 #15 | 2020-08-06 ✅ Patent 11,458,133 granted on 2022-10-04
US20200246326A1
Human necessities

Methods for solid tumor treatment

 #16 | 2020-06-18 ✅ Patent 10,894,045 granted on 2021-01-19
US20200188384A1
Human necessities

Methods for solid tumor treatment

 #17 | 2020-05-28 ✅ Patent 10,729,673 granted on 2020-08-04
US20200163928A1
Human necessities

Taxane particles and their use

 #18 | 2020-04-02 ✅ Patent 11,123,322 granted on 2021-09-21
US20200101039A1
Human necessities

Taxane particles and their use

 #19 | 2020-02-27 ✅ Patent 11,160,754 granted on 2021-11-02
US20200060969A1
Human necessities

Methods for treating lung disorders

 #20 | 2019-11-14 ✅ Patent 11,033,542 granted on 2021-06-15
US20190343824A1
Human necessities

Methods for solid tumor treatment

 #21 | 2019-10-17 ✅ Patent 10,507,181 granted on 2019-12-17
US20190314277A1
Human necessities

Methods for treating lung disorders

 #22 | 2019-01-24 ✅ Patent 10,391,090 granted on 2019-08-27
US20190022081A1
Human necessities

Methods for solid tumor treatment

 #23 | 2018-12-20 ✅ Patent 10,398,646 granted on 2019-09-03
US20180360748A1
Human necessities

Methods for treating lung disorders

 #24 | 2018-08-09
US20180221849A1
Performing operations; transporting

Equipment Assembly for and Method of Processing Particles

 #25 | 2018-06-21 ✅ Patent 10,507,195 granted on 2019-12-17
US20180169058A1
Human necessities

Taxane particles and their use

 #26 | 2018-05-10 ✅ Patent 11,291,646 granted on 2022-04-05
US20180125783A1
Human necessities

Nozzle assembly and methods for use

 #27 | 2018-05-03 ✅ Patent 10,751,319 granted on 2020-08-25
US20180116910A1
Human necessities

Collection device and methods for use

 #28 | 2017-08-10 ✅ Patent 9,918,957 granted on 2018-03-20
US20170224650A1
Human necessities

Methods for making compound particles

 #29 | 2016-12-08 ✅ Patent 9,814,685 granted on 2017-11-14
US20160354336A1
Human necessities

Taxane particles and their use

 #30 | 2015-12-31 ✅ Patent 9,925,512 granted on 2018-03-27
US20150375153A1
Performing operations; transporting

Equipment assembly for and method of processing particles

 #31 | 2015-12-03
US20150342872A1
Human necessities

Use of Paclitaxel Particles

 #32 | 2014-10-02 ✅ Patent 9,233,348 granted on 2016-01-12
US20140296140A1
Performing operations; transporting

Equipment assembly for and method of processing particles

 #33 | 2014-07-15 ✅ Patent 8,778,181 granted on 2014-07-15
US13911700
Human necessities

Equipment assembly for and method of processing particles

 #34 | 2009-08-06 ✅ Patent 8,221,779 granted on 2012-07-17
US20090197821A1
Human necessities

Compositions and methods for the delivery of poorly water soluble drugs and methods of treatment

 #35 | 2008-04-17 ✅ Patent 7,744,923 granted on 2010-06-29
US20080089944A1
Human necessities

Method for precipitation of small medicament particles into use containers

Also check out CRITITECH, INC.'s (Lawrence, United States) applicant profile with 36 patent applications submitted.

AssigneeID:

78998 ⎘